2014
DOI: 10.1007/s00702-014-1320-1
|View full text |Cite
|
Sign up to set email alerts
|

Aldehyde dehydrogenase (ALDH) in Alzheimer’s and Parkinson’s disease

Abstract: Evidence suggests that aldehyde dehydrogenase (ALDH; E.C. 1.2.1.3) gene, protein expression and activity are substantially decreased in the substantia nigra of patients with Parkinson's disease (PD). This holds especially true for cytosolic ALDH1A1, while mitochondrial ALDH2 is increased in the putamen of PD. Similarly, in Alzheimer's disease (AD) several studies in genetic, transcriptomic, protein and animal models suggest ALDH involvement in the neurodegeneration processes. Such data are in line with finding… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
50
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 69 publications
(50 citation statements)
references
References 56 publications
0
50
0
Order By: Relevance
“…RA is the locally synthesized, tightly regulated, active metabolite of vitamin A, which may be considered as one of the most potent endogenous small molecules in the central nervous system (CNS), controlling important neurobiological processes throughout life. RA is locally synthesized through retinol dehydrogenases (ROLDHs) and aldehyde dehydrogenases (ALDHs), and strong evidence suggests variation at the genetic and protein expression level to be implicated in the pathogenesis of neurodegenerative disorders (Grunblatt and Riederer 2014). Acting via nuclear receptor-mediated (RAR-a,b,c and RXR-a,b,c) transcriptional regulation of neuroprotective and pro-differentiative genes, a specific involvement of RA signaling in key homeostatic-and depression-related-processes has been shown.…”
Section: Introductionmentioning
confidence: 99%
“…RA is the locally synthesized, tightly regulated, active metabolite of vitamin A, which may be considered as one of the most potent endogenous small molecules in the central nervous system (CNS), controlling important neurobiological processes throughout life. RA is locally synthesized through retinol dehydrogenases (ROLDHs) and aldehyde dehydrogenases (ALDHs), and strong evidence suggests variation at the genetic and protein expression level to be implicated in the pathogenesis of neurodegenerative disorders (Grunblatt and Riederer 2014). Acting via nuclear receptor-mediated (RAR-a,b,c and RXR-a,b,c) transcriptional regulation of neuroprotective and pro-differentiative genes, a specific involvement of RA signaling in key homeostatic-and depression-related-processes has been shown.…”
Section: Introductionmentioning
confidence: 99%
“…Accumulating evidence supports the view that in synucleinopathies putamen dopamine depletion reflects not only denervation but also a variety of functional abnormalities in the residual terminals. These abnormalities include decreased activity of aldehyde dehydrogenase (ALDH) [10,11] or L-aromatic-amino-acid decarboxylase [12,13], decreased vesicular storage of cytoplasmic dopamine [1416], and oxidative stress related to dopamine-based free radicals [17]. …”
mentioning
confidence: 99%
“…), confirming the role of this gene in alcohol metabolism. ALDH1A1 , the protein product that also catalyzes conversion of retinaldehyde to retinoic acid, is involved in different molecular processes, such as regulation of marrow adiposity, anti‐oxidant defense, carcinogenesis and neurodegeneration (Grunblatt & Riederer ; Li et al . ; Nallamshetty et al .…”
Section: Discussionmentioning
confidence: 99%